Virios Therapeutics Inc
Change company Symbol lookup
Select an option...
VIRI Virios Therapeutics Inc
TCBS Texas Community Bancshares Inc
UPC Universe Pharmaceuticals Inc
MHH Mastech Digital Inc
GCTK GlucoTrack Inc
KODK Eastman Kodak Co
FYBR Frontier Communications Parent Inc
TPNEF Cub Energy Inc
ECC Eagle Point Credit Co LLC
CPHI China Pharma Holdings Inc
Go

Health Care : Biotechnology |
Company profile

Virios Therapeutics, Inc., formerly Virios Therapeutics, LLC., is a development-stage biotechnology company focused on advancing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response, such as fibromyalgia (FM). Its lead development candidate is IMC-1, which is a fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination antiviral therapy designed to synergistically suppress Herpes Simplex Virus-1 (HSV-1) activation and replication. Its HSV-1 root cause of chronic illnesses such as FM, irritable bowel disease (IBS), chronic fatigue syndrome and functional somatic syndrome. The Company is developing its initial candidate, IMC-1, for people who are suffering from fibromyalgia.

Closing Price
$6.15
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
60,939
0

MGM Resorts International Stock Outperforms Competitors On Strong Trading Day

5:07 pm ET May 26, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of MGM Resorts International (MGM) advanced 7.45% to $34.48 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.99% to 4,057.84 and the Dow Jones Industrial Average rising 1.61% to 32,637.19. This was the stock's second consecutive day of gains. MGM Resorts International closed $16.69 short of its 52-week high ($51.17), which the company achieved on November 8th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Las Vegas Sands Corp. (LVS) rose 6.55% to $34.17, Wynn Resorts Ltd. (WYNN) rose 7.89% to $64.43, and Melco Resorts & Entertainment Ltd. ADR (MLCO) rose 9.05% to $5.18. Trading volume (8.3 M) eclipsed its 50-day average volume of 5.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 26, 2022.

	

(END) Dow Jones Newswires

May 26, 2022 17:07 ET (21:07 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.